Timolol-latanoprost P-f (0.5 recalls

The FDA has published 1 recall involving Timolol-latanoprost P-f (0.5 since 2019. The latest was reported on 7 Aug 2019. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 7 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why timolol-latanoprost p-f (0.5 is recalled

Potency & Assay1100%

Companies

ImprimisRx NJ1100%

By year

20191100%

All timolol-latanoprost p-f (0.5 recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
7 Aug 2019Drug	CLASS II	Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops recalled	ImprimisRx NJ	Potency & Assay	Nationwide

Should you stop taking Timolol-latanoprost P-f (0.5?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.